✦ LIBER ✦

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

✍ Scribed by Su-su Liao; Rong-cheng Li; Hui Li; Jin-ye Yang; Xian-jia Zeng; Jian Gong; Shu-sheng Wang; Yan-ping Li; Kong-lai Zhang

Book ID: 117433325
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 330 KB
Volume: 17
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(99)00031-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nine-year follow-up study of a plasma-de

Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African setting

✍ Edward Tabor; James Cairns; Robert J. Gerety; Anne C. Bayley 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

## Abstract One hundred and one of 255 recipients of a plasma‐derived hepatitis B vaccine were evaluated in 1990, 9 years after the first vaccine dose in a study in Zambia to evaluate the efficacy of one, two, or three doses. In 1983, 2 years after the first vaccine dose, antibody to the hepatitis

Hepatitis B immunity in children vaccina

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years

✍ Laura L. Hammitt; Thomas W. Hennessy; Anthony E. Fiore; Carolyn Zanis; Kimberlee 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB

P.352 Efficacy of hepatitis B vaccine in

P.352 Efficacy of hepatitis B vaccine in preventing clinical hepatitis B in children: a 13 years follow-up

✍ J. Gong; R.C. Li; J.Y. Yang; X.R. Chen; C.B. Liu; K. Zhao 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A follow-up study of combined vaccinatio

A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants

✍ Ping-Ing Lee; Chin-Yun Lee; Li-Min Huang; Jong-Min Chen; Mei-Hwei Chang 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Twelve-year follow-up of a prospective r

Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children

✍ Man-Fung Yuen; Wei-Ling Lim; Chi-Chung Cheng; Shiu-Kam Lam; Ching-Lung Lai 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

A total of 318 children were prospectively randomized in group 1 with two 5-g doses of recombinant vaccine given at 0 and 1 month; in group 2 with three 5-g doses of recombinant vaccine given at 0, 1, and 6 months; or in group 3 with three doses of plasma-derived vaccine given at 0, 1, and 6 months.

Favorable efficacy of long-term lamivudi

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study

✍ Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Hitomi Sezaki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract The long‐term efficacy of lamivudine therapy in patients with hepatitis B virus (HBV) infection is still not clear. In this study, 20 non‐cirrhotic Japanese patients infected with HBV received lamivudine therapy for more than 1 year and were followed for a median period of 8.5 years (ra